Stock Radar: Strides Pharma breaks out from 7-month consolidation to hit fresh 52-week high; time to buy?

Strides Pharma Science stock shows positive movement. It broke a seven-month consolidation phase. Experts suggest a buy with a target of Rs 960 in 1-2 months. The stock demonstrated strong momentum, breaking resistance at Rs 760. Technical indicators support a bullish outlook. A stop loss is advised at Rs 750 for risk management. Market participation has increased.